Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Karen Lutrick
Associate Professor, Family and Community Medicine - (Research Scholar Track)
Family and Community Medicine
Overview
Research
More
Collaboration
(86)
Mindy Fain
Mutual work: 3 Proposals
Collaboration Details
Sairam Parthasarathy
Mutual work: 2 Grants﹒6 Proposals
Collaboration Details
Hao Zhang
Mutual work: 1 Proposal
Collaboration Details
Sonia Colina
Mutual work: 1 Proposal
Collaboration Details
Jarrod Mosier
Mutual work: 4 Grants﹒8 Proposals﹒5 Publications
Collaboration Details
Page 1 of 18
Previous page
Next page
Grants
(20)
Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subje
Active
·
2023
·
$0 / $1.5M
·
External
Co-Investigator (COI)
pharmaceuticals,
clinical trials,
drug efficacy,
safety assessment,
standard of care
SCCM Datathon Data Preparation
Active
·
2023
·
$60K / $15K
·
External
Principal Investigator (PI)
data analysis,
it management,
software development,
machine learning,
data visualization
Prospective Cohort to Evaluate the Immunogenicity and Effectiveness of COVID-19 Vaccines Among Previously Infected and Uninfected Essential and Frontline Workers in a US State or Region
Active
·
2022
·
$7.4M / $22.4M
·
External
Co-Investigator (COI)
covid-19 vaccines,
immunogenicity,
effectiveness,
frontline workers,
prospective cohort
A Multicenter, Adaptive, Randomized, Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections / Appendix E-1: Shio
Active
·
2022
·
$0 / $1.5M
·
External
Co-Investigator (COI)
respiratory infections,
hospitalized patients,
treatment strategies,
randomized controlled trial,
efficacy evaluation
Laboratory-Confirmed Influenza among Adults Aged 18-64 Years: A Pilot Study to Assess Enrollment Strategies, Infection Surveillance and Sample Collection
Active
·
2022
·
$3.5M / $1.2M
·
External
Principal Investigator (PI)
influenza,
infection surveillance,
sample collection,
enrollment strategies
Page 1 of 4
Previous page
Next page
Publications
(54)
Recent
Temporal Changes in Vaccine-Specific Willingness Across Race/Ethnicity Following Serious Adverse Event Reports
2024
vaccine hesitancy,
public health,
adverse events,
race/ethnicity,
epidemiology
Disease and social factors associated with healthcare utilization for the treatment of SARS-CoV-2 infections in a longitudinal cohort of essential workers in Arizona
2023
infectious diseases,
healthcare utilization,
social factors,
longitudinal cohort,
essential workers
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022
2023
immune response,
mrna vaccination,
children,
covid-19
Household Transmission of Influenza A Viruses in 2021-2022
2023
influenza transmission,
household,
influenza a viruses,
public health
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic
2023
hospital stress,
covid-19,
care process,
sars-cov-2 activity,
temporal variance
Determinants of B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections
2023
b cell responses,
sars-cov-2,
vaccination,
epitopes,
immunology
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
2023
covid-19,
post-acute sequelae,
infection,
healthcare,
epidemiology
Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals
2023
covid-19,
antiviral treatment,
viral loads,
outpatient care,
propensity score matching
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
2023
sars-cov-2,
reinfection,
omicron variant,
risk factors,
frontline workers
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies
2023
chemical exposure,
antibody response,
vaccination,
viral infection,
serum concentrations